Both in Pharmaceuticals
Parabilis Medicines vs Amylyx Pharmaceuticals
Over the past year PBLS returned −27.5% and AMLX returned −12.2%; their daily moves had a correlation of 0.60.
PBLS −27.5% AMLX −12.2%Growth of $1, one year, split-adjusted
| Metric | PBLS | AMLX |
|---|---|---|
| Price | $26.75 | $27.77 |
| Market cap | $3.30B | $3.49B |
| Today | +0.91% | −1.87% |
| 1 month | −16.2% | −5.2% |
| 6 months | — | +78.0% |
| Year to date | — | +129.9% |
| 1 year | — | +95.2% |
| Revenue growth (YoY) | — | — |
| Gross margin | 100.0% | — |
| Net margin | −45239.9% | — |
| P/E (TTM) | — | — |
| Price / sales | — | — |
| Net cash | $1.11B | $250.8M |
| Dividend yield | — | — |
| Volatility (60d) | — | 114.5% |
| Short % of float | 9.1% | 13.7% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).